Celecoxib
- Product NDC
- 69680-135
- 11-digit product format
- 696800135
- Labeler code
- 69680
- Product ID
- 69680-135_c8ce096d-04ef-4d01-8b3e-0dd661bbdcd2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Celecoxib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Vitruvias Therapeutics
- Application
- ANDA213598
- Marketing category
- ANDA
- Marketing start
- 2020-11-20
- Marketing end
- 0000-00-00
- Substance
- CELECOXIB
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69680-135-00 | 69680013500 | 100 CAPSULE in 1 BOTTLE (69680-135-00) | 100 capsule | 2020-11-20 | 0000-00-00 | No | No | Current |